untransl
region
utr
coxsackieviru
rna
form
highli
order
secondari
structur
confirm
play
import
regulatori
role
viral
capindepend
intern
translat
initi
rna
replic
previous
demonstr
delet
differ
region
utr
significantli
reduc
viral
rna
translat
infect
observ
suggest
strongli
viral
rna
translat
replic
could
block
highli
specif
antisens
oligodeoxynucleotid
asodn
appli
target
crucial
site
within
utr
studi
seven
phosphorothio
asodn
synthes
antivir
activ
evalu
lipofectin
transfect
hela
cell
asodn
follow
infect
analysi
western
blot
revers
transcriptionpcr
viral
plaqu
assay
demonstr
viral
protein
synthesi
genom
replic
infect
strongli
inhibit
asodn
complementari
differ
region
utr
effect
site
locat
proxim
terminu
utr
proxim
terminu
utr
core
sequenc
intern
ribosom
entri
site
translat
initi
codon
region
asodn
show
highli
sequencespecif
dosedepend
inhibitori
effect
viral
protein
synthesi
rna
replic
noteworthi
highest
inhibitori
activ
obtain
target
termini
utr
percent
inhibit
valu
protein
synthesi
rna
replic
respect
data
suggest
infect
inhibit
effect
asodn
coxsackieviru
member
genu
enteroviru
famili
picornavirida
viru
import
viral
myocard
pathogen
human
anim
import
reflect
data
world
health
organ
global
surveil
viral
diseas
coxsacki
b
virus
rank
number
one
caus
clinic
evid
cardiovascular
diseas
addit
consider
clinic
experiment
evid
indic
dilat
cardiomyopathi
anoth
common
heart
diseas
may
late
consequ
viral
myocard
singlestrand
positivepolar
rna
viru
like
picornavirus
untransl
region
utr
genom
unusu
long
nucleotid
nt
unlik
eukaryot
mrna
cap
triphosph
group
instead
coval
link
virusencod
oligopeptid
vpg
viral
genom
approxim
kb
long
polyadenyl
tail
end
primari
sequenc
genom
rna
serv
mrna
direct
synthesi
viral
protein
use
host
protein
translat
machineri
picornaviru
rna
encod
singl
long
polyprotein
process
initi
three
precursor
polyprotein
process
precursor
three
virusencod
proteas
give
rise
matur
structur
nonstructur
protein
includ
four
capsid
protein
rnadepend
rna
polymeras
essenti
viral
replic
long
known
major
cellular
mrna
eukaryot
organ
initi
translat
via
capdepend
ribosom
scan
mechan
howev
initi
protein
translat
picornavirus
occur
unusu
mechan
involv
direct
intern
bind
ribosom
sequenc
element
utr
viral
rna
term
intern
ribosom
entri
site
ire
ire
direct
bind
small
ribosom
subunit
viral
rna
near
border
ire
independ
cap
structur
terminu
rna
recent
work
confirm
presenc
ire
within
utr
rna
mutat
analysi
use
bicistron
plasmid
fulllength
mutant
map
variou
mutat
demonstr
crucial
sequenc
ire
locat
roughli
stemloop
g
h
span
nt
critic
sequenc
analyz
sitedirect
mutagenesi
demonstr
critic
nucleotid
ire
span
pyrimidinerich
tract
stemloop
g
h
delet
region
abolish
viral
translat
infect
therefor
ire
play
import
role
translat
initi
viral
protein
addit
recent
work
also
found
proxim
terminu
utr
critic
translat
initi
delet
nt
utr
greatli
inhibit
translat
similar
find
report
picornavirus
suggest
cloverleaf
structur
utr
may
respons
viral
replic
addit
recent
report
suggest
utr
sever
picornavirus
involv
viral
rna
replic
thu
block
crucial
site
within
utr
sequencespecif
hybrid
viral
protein
translat
rna
replic
inhibit
antisens
rna
dna
oligonucleotid
consid
promis
agent
inhibit
viral
replic
due
part
high
specif
viral
rna
sequenc
agent
success
employ
inhibit
human
immunodefici
viru
hepat
b
c
viru
influenzaviru
coronaviru
respiratori
syncyti
viru
recent
food
drug
administr
approv
first
asbas
therapeut
product
treatment
retin
caus
cytomegaloviru
infect
patient
aid
although
viral
replic
could
inhibit
unmodifi
oligonucleotid
vulner
nucleas
attack
combin
intracellular
distribut
uptak
properti
limit
therapeut
potenti
avoid
problem
improv
cellular
uptak
oligonucleotid
phosphorothio
oligodeoxynucleotid
odn
encapsul
liposom
use
studi
mode
action
highli
specif
essenti
care
select
appropri
viral
target
sequenc
base
previou
mutat
map
report
picornavirus
utr
rna
chosen
major
target
design
odn
report
seven
asodn
synthes
evalu
hela
cell
infect
four
seven
show
specif
dosedepend
inhibit
gene
express
two
four
target
proxim
termini
genom
rna
demonstr
strongest
antivir
activ
design
synthesi
asodn
odn
target
utr
design
base
previou
mutat
map
cisand
transact
translat
sequenc
element
put
translat
initi
factor
bind
site
ire
surround
sequenc
initi
codon
odn
locat
utr
design
accord
tertiari
structur
utr
rna
three
odn
target
utr
design
disrupt
kiss
interact
two
predomin
hairpin
loop
avoid
use
mani
control
oligom
first
round
evalu
odn
ass
length
averag
gc
content
random
sequenc
design
gener
control
seven
odn
highest
inhibitori
activ
obtain
two
asodn
chosen
evalu
specif
use
two
new
control
design
scrambl
revers
sequenc
respect
control
analyz
dna
strider
softwar
avoid
sequenc
complement
genom
rna
asodn
synthes
standard
phosphoramidit
chemistri
method
use
appli
biosystem
dnarna
synthes
scale
biotechnolog
laboratori
univers
british
columbia
order
replac
phosphodiest
bond
within
oligonucleotid
phosphorothio
oxid
step
substitut
sulfur
procedur
use
beaucag
reagent
oligonucleotid
deriv
purifi
reversephas
highpressur
liquid
chromatographi
lyophil
powder
dissolv
distil
water
oligonucleotid
figur
show
locat
asodn
within
utr
rna
use
investig
asodn
sequenc
shown
tabl
viru
cell
cultur
transfect
stock
gener
provid
reinhard
kandolf
store
viru
grown
hela
cell
american
type
cultur
collect
titer
routin
redetermin
begin
individu
experi
transfect
hela
cell
odn
conduct
plate
hela
cell
seed
plate
cellswel
grown
minimum
essenti
medium
mem
contain
fetal
calf
serum
incub
h
cell
reach
confluenc
wash
phosphatebuff
salin
pb
transfect
mixtur
contain
asodn
final
concentr
g
lipofectin
gibcobrl
l
optimedium
gibcobrl
ad
well
transfect
mixtur
prepar
follow
steril
tube
l
lipofectin
ad
l
optimedium
mix
well
gentli
kept
room
temperatur
min
anoth
steril
tube
l
oligonucleotid
appropri
concentr
ad
l
optimedium
sampl
mix
well
gentli
kept
room
temperatur
min
two
tube
combin
mix
well
kept
room
temperatur
anoth
min
hela
cell
overlaid
final
transfect
mixtur
lipofectinodn
lwell
incub
h
cell
wash
pb
infect
l
supernat
multipl
infect
moi
min
infect
cell
wash
pb
overlaid
l
complet
mem
incub
h
humidifi
co
incub
final
supernat
treatment
collect
centrifug
g
min
result
supernat
aliquot
kept
use
western
blot
detect
structur
protein
thirti
microlit
result
supernat
odn
treatment
denatur
min
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sampl
transfer
nitrocellulos
membran
v
min
membran
block
pb
contain
tween
milk
room
temperatur
h
incub
primari
antibodi
rabbit
immunoglobulin
g
denka
seiken
co
ltd
dilut
overnight
membran
wash
pb
contain
tween
min
incub
secondari
antibodi
antirabbit
immunoglobulin
g
conjug
horseradish
peroxidas
transduct
ltd
membran
wash
min
signal
detect
conduct
enhanc
chemiluminesc
method
per
manufactur
instruct
amersham
pharmacia
biotech
inc
film
analyz
densitometr
scan
band
densiti
valu
repres
mean
standard
deviat
sd
mean
sd
control
normal
valu
mean
sd
valu
treatment
group
calcul
respect
control
valu
experi
perform
four
time
detect
rna
rtpcr
one
hundr
microlit
supernat
contain
particl
treatment
ad
ml
trizol
reagent
gibcobrl
viral
rna
extract
follow
procedur
describ
instruct
manual
final
step
pellet
dissolv
l
diethyl
pyrocarbonatetr
water
kept
revers
transcript
rt
conduct
accord
manufactur
instruct
gibcobrl
use
l
extract
rna
l
rt
primer
gcattcagcctggtctca
nt
rna
genom
incub
min
sampl
heat
min
stop
reaction
order
amplifi
cdna
pcr
carri
follow
standard
method
volum
l
contain
l
rt
product
l
upstream
primer
agcctgtgggttgatcccac
nt
l
downstream
primer
aattgtcaccataagc
agcca
nt
reaction
run
cycl
follow
paramet
denatur
anneal
extens
neg
control
water
substitut
cdna
twenti
microlit
pcr
product
sampl
analyz
agaros
gel
electrophoresi
band
scan
use
densitomet
mean
densiti
band
calcul
describ
experi
repeat
three
time
plaqu
assay
viral
plaqu
assay
carri
use
supernat
collect
hela
cell
monolay
treat
asodn
final
concentr
hela
cell
seed
plate
cellswel
incub
h
cell
confluenc
reach
approxim
cell
wash
pb
remov
fetal
bovin
serum
overlaid
ml
supernat
dilut
cell
incub
min
supernat
remov
cell
wash
pb
final
cell
overlaid
ml
steril
soft
bacto
agarmem
bacto
mem
cell
incub
h
fix
carnoy
fix
acet
acid
min
stain
crystal
violet
plaqu
count
viral
pfu
per
millilit
calcul
supernat
hela
cell
monolay
treat
control
asodn
use
control
experi
repeat
three
time
inhibitori
activ
asodn
calcul
respect
valu
correspond
control
statist
analysi
valu
express
mean
sd
statist
signific
evalu
use
student
test
pair
comparison
p
valu
consid
statist
signific
establish
optim
vitro
evalu
system
use
hela
cell
three
paramet
test
first
cell
confluenc
optim
cell
confluenc
transfect
usual
howev
cell
confluenc
hard
determin
effect
asodn
viral
multipl
transfect
cell
die
quickli
h
infect
observ
attribut
high
transfect
effici
lead
nonspecif
toxic
cell
especi
high
oligonucleotid
concentr
seri
experi
found
optim
cell
confluenc
asodn
transfect
follow
infect
even
though
transfect
effici
would
somewhat
affect
second
consider
moi
unlik
virus
fig
target
asodn
within
propos
secondari
structur
utr
rna
utr
nt
contain
three
asodn
block
site
block
proxim
terminu
utr
nt
nt
nt
target
ire
region
complementari
polypyrimidin
tract
ire
core
sequenc
target
downstream
region
near
boundari
ire
nt
block
translat
initi
codon
aug
region
includ
nt
utr
within
utr
nt
three
asodn
target
select
nt
nt
target
stemloop
l
respect
nt
block
proxim
terminu
utr
gener
scrambl
oligom
control
ass
synthes
length
random
sequenc
anneal
target
genom
rna
addit
oligom
control
list
oligom
togeth
tabl
replic
assembl
fast
hela
cell
therefor
import
choos
suitabl
moi
evalu
antivir
effect
asodn
effect
moi
test
asodn
final
concentr
found
moi
best
choic
experi
meaning
inhibitori
effect
obtain
condit
third
paramet
dosag
asodn
odn
two
differ
final
concentr
evalu
optim
condit
mention
ten
micromolar
appear
best
dosag
vitro
evalu
system
see
fig
condit
addit
experi
conduct
transfect
control
odn
ass
determin
toxic
effect
hela
cell
growth
treatment
use
lipofectin
ass
neg
control
result
demonstr
signific
differ
ass
lipofectin
group
term
cell
growth
synthesi
rna
replic
indic
ass
reliabl
control
asodn
data
shown
last
activ
correspond
scrambl
revers
odn
control
simpli
ad
cell
cultur
without
transfect
h
cellular
toxic
hela
cell
term
morpholog
cell
count
found
inhibitori
effect
asodn
protein
synthesi
evalu
effect
asodn
translat
viral
structur
protein
detect
western
blot
transfect
sinc
rna
encod
singl
long
polyprotein
includ
structur
nonstructur
protein
synthesi
structur
protein
fulli
repres
translat
effici
order
compar
antivir
action
asodn
negativecontrol
oligom
ass
statist
analyz
mean
sd
normal
valu
convert
mean
control
group
ass
two
differ
dose
odn
use
evalu
antivir
activ
concentr
odn
use
fig
sever
oligom
show
potent
antivir
activ
oligom
block
termini
utr
show
strongest
inhibitori
effect
synthesi
compar
neg
control
ass
percent
inhibit
valu
synthesi
respect
howev
mark
inhibitori
activ
observ
group
contrari
odn
slightli
stimul
synthesi
may
due
experiment
variat
sinc
similar
result
obtain
evalu
odn
evalu
also
perform
final
asodn
concentr
similar
inhibitori
pattern
observ
lower
degre
inhibit
fig
compar
treatment
dosag
percentag
inhibit
synthesi
respect
signific
inhibitori
activ
observ
base
first
round
evalu
two
activ
oligom
chosen
evalu
specif
two
oligom
confirm
use
addit
correspond
scrambl
revers
sequenc
neg
control
dosag
percent
inhibit
valu
synthesi
compar
scrambl
control
valu
signific
differ
scrambl
oligom
similar
inhibitori
result
obtain
revers
control
group
name
fig
inhibitori
effect
asodn
rna
replic
evalu
effect
asodn
replic
viral
genom
rna
amplifi
quantit
analyz
rtpcr
densitometri
perform
pcr
differ
number
cycl
found
cycl
optim
demonstr
signific
differ
among
sampl
treat
differ
asodn
order
compar
antivir
action
asodn
negativecontrol
oligom
statist
analyz
mean
sd
normal
valu
convert
cdna
mean
control
group
ass
two
differ
dose
asodn
use
evalu
antivir
activ
odn
appli
fig
inhibitori
trend
rna
synthesi
quit
similar
seen
synthesi
seven
oligom
block
termini
utr
respect
show
strongest
antivir
activ
compar
control
oligom
ass
percentag
inhibit
respect
remark
inhibitori
effect
rna
synthesi
asodn
employ
similar
data
obtain
fig
percentag
inhibit
rna
synthesi
respect
signific
inhibitori
effect
observ
group
evalu
conduct
confirm
specif
potent
oligom
signific
differ
antivir
activ
scrambl
oligom
similar
data
obtain
revers
control
oligom
fig
viral
plaqu
assay
employ
measur
antivir
activ
asodn
optim
dosag
determin
viral
plaqu
count
day
overlay
soft
agar
hela
cell
monolay
fig
number
pfu
per
millilit
calcul
normal
data
negativecontrol
ass
found
asodn
show
strongest
antivir
activ
follow
show
slight
inhibit
plaqueform
abil
howev
demonstr
notic
inhibit
infect
result
correl
well
obtain
measur
inhibitori
effect
product
rna
replic
observ
confirm
plaqu
assay
correspond
control
mention
percent
inhibit
valu
infect
normal
scrambl
revers
control
respect
fig
import
factor
determin
effect
specif
asodn
select
target
site
within
rna
unusu
long
utr
rna
form
highli
order
secondari
structur
play
import
role
control
viral
translat
replic
cardiovirul
recent
mutat
map
ire
confirm
ribosom
initi
translat
bind
polypyrimidin
stretch
ire
utr
migrat
aug
initi
codon
situat
asodn
presum
block
translat
inhibit
bind
ribosom
andor
rnabind
protein
essenti
form
ribosom
complex
migrat
ribosom
subunit
along
mrna
therefor
possibl
asodn
function
translat
arrest
block
land
ribosom
andor
rnabind
protein
ire
fig
addit
note
polypyrimidin
tract
locat
stemloop
g
h
nt
appear
open
singlestrand
structur
base
computerpredict
secondari
structur
model
impli
asodn
easili
form
stabl
hybrid
region
point
view
obviou
asodn
show
potent
inhibitori
effect
anoth
asodn
also
bind
ire
region
show
potenc
inhibit
synthesi
target
site
hairpinlik
secondari
structur
difficult
form
stabl
duplex
viral
sequenc
similar
situat
occur
target
two
hairpinlik
structur
utr
cover
translat
start
codon
strong
inhibitori
effect
expect
sinc
asodn
block
translat
initi
codon
theoret
show
certain
degre
inhibitori
effect
mrna
translat
initi
similar
observ
report
investig
interestingli
two
asodn
strongest
inhibitori
effect
locat
end
rna
known
utr
rna
form
highli
order
tertiari
structur
serv
recognit
featur
rnabind
domain
host
protein
import
cisact
function
replic
translat
rna
evid
date
suggest
cloverleaf
structur
polioviru
form
nt
rna
bind
viral
protein
host
protein
kda
cellular
factor
specif
bind
utr
polioviru
coxsackieviru
rhinoviru
detect
mutat
within
utr
decreas
affin
rna
cellular
factor
decreas
rna
replic
viru
viabil
furthermor
concurr
uv
crosslink
experi
suggest
certain
host
protein
abl
interact
utr
nt
utr
nt
termin
region
genom
p
k
cheung
c
carthi
l
bohunek
k
wang
j
e
wilson
b
mcmanu
c
yang
unpublish
data
extens
stemloop
secondari
structur
within
utr
like
recognit
site
certain
common
bind
protein
connect
end
viral
genom
interact
end
viral
genom
via
common
bind
protein
suggest
play
crucial
role
viral
replic
possibl
translat
initi
addit
evid
viral
utr
interact
enhanc
viral
translat
andor
transcript
henc
closedloop
translat
model
mrna
propos
thu
block
termin
region
rna
either
utr
utr
possibl
inhibit
bind
cellular
protein
serv
translat
replic
initi
factor
turn
block
format
circular
replic
unit
viral
rna
mechan
may
explain
two
asodn
block
termini
rna
show
power
inhibitori
effect
addit
translat
replic
may
affect
therebi
result
negativefeedback
effect
translat
inhibit
synthesi
structur
protein
nonstructur
protein
includ
rnadepend
rna
polymeras
essenti
viru
replic
reduc
make
difficult
viral
rna
transcript
particl
assembl
occur
decreas
viral
rna
synthesi
turn
reduc
translat
effici
importantli
asodn
may
block
land
translat
machineri
also
bind
protein
factor
requir
within
viral
rna
gene
express
therefor
asodn
inhibit
gene
express
translat
transcript
level
pattern
inhibit
observ
studi
consid
sequenc
specif
regard
strict
odn
control
scrambl
revers
use
howev
still
argu
antivir
effect
may
due
part
socal
sequencedepend
nonantisens
effect
sequencespecif
interact
odn
cellular
protein
occur
sinc
asodn
produc
notabl
neg
effect
hela
cell
growth
test
toxic
possibl
unlik
addit
sever
report
indic
nonsequencespecif
effect
odn
particularli
chemic
modifi
molecul
exampl
odn
bind
sequenceindepend
manner
protein
human
immunodefici
viru
type
viral
polymeras
rnase
h
bovin
serum
albumin
receptor
plateletderiv
growth
factor
cellular
protein
whether
similar
event
happen
need
explor
futur
determin
detail
mechan
antivir
action
oligom
conclus
phosphorothio
odn
target
termini
utr
core
sequenc
ire
translat
initi
codon
region
possess
specif
strong
activ
first
report
demonstr
translat
replic
tissu
cultur
cell
specif
inhibit
asodn
observ
suggest
oligom
great
potenti
develop
effect
amelior
therapeut
agent
control
coxsackievirusinduc
heart
pancrea
brain
liver
muscl
diseas
